Session Information
2011 Midyear Clinical Meeting
Click here to go to the previous page
Pharmacotherapy Update in Rheumatoid Arthritis and Osteoarthritis
Track:
Education Sessions (CE)
Program Code: 229-L01
Date: Tuesday, December 6, 2011
Time: 9:00 AM to 11:00 AM EST
Location:
Room 354, Level 3
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Eric MacLaughlin, PharmD, BCPS, Associate Professor and Division Head of Adult Medicine, Texas Tech School of Pharmacy
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
- Describe the effectiveness of available treatment options for the management of osteoarthritis.
- Identify similarities and differences among the available biologic disease-modifying antirheumatic drugs (DMARDs) used to treat patients with rheumatoid arthritis.
- List at least two long-term toxicities associated with the chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs) and identify management strategies.
- Summarize the role in therapy of disease-modifying antirheumatic drugs (DMARDs) including biologic agents, in the management of rheumatoid arthritis.
This session is a part of:
This session is a part of: